How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Co-administration of Dynapar AQ 75 mg Injection 1 ml with Meloxicam can increase the risk or severity of gastrointestinal side effects.
How to manage the interaction:
Taking Meloxicam with Dynapar AQ 75 mg Injection 1 ml is not recommended as it can possibly result in an interaction, it can be taken if your doctor has advised it. However, consult your doctor immediately if you experience symptoms such as dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness. Do not stop any medication without doctor's advise.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Taking Dynapar AQ 75 mg Injection 1 ml with human immunoglobulin may increase the risk of kidney problems.
How to manage the interaction:
Although there is an interaction between Human immunoglobulin and Dynapar AQ 75 mg Injection 1 ml, you can take these medicines together if prescribed by a doctor. However, consult the doctor immediately if you experience symptoms such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Taking Dynapar AQ 75 mg Injection 1 ml and ibuprofen can increase the risk of stomach bleeding and ulcers.
How to manage the interaction:
Co-administration of Dynapar AQ 75 mg Injection 1 ml and Ibuprofen can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Co-administration of Dynapar AQ 75 mg Injection 1 ml with Sirolimus may increase the risk or severity of kidney problems.
How to manage the interaction:
Co-administration of Dynapar AQ 75 mg Injection 1 ml and Sirolimus can lead to an interaction, but it can be taken if advised by a doctor. However, consult a doctor if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Co-administration of Dynapar AQ 75 mg Injection 1 ml and sulindac can increase the risk of side effects.
How to manage the interaction:
Although there is a interaction between Dynapar AQ 75 mg Injection 1 ml and sulindac, it can be taken if advised by your doctor. However, if you experience any symptoms like unusual bleeding or bruising, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headache, and weakness, consult your doctor immediately. Do not stop using any medications without a doctor's advice.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Coadministration of Dynapar AQ 75 mg Injection 1 ml with fondaparinux may increase the risk of bleeding.
How to manage the interaction:
There may be a possible interaction between Dynapar AQ 75 mg Injection 1 ml and Fondaparinux when taken together, but they can be taken together if your doctor has prescribed them. However, if you experience bleeding, severe back pain, dizziness, black or red stools, severe headache, weakness, and vomiting contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Coadministration of Dynapar AQ 75 mg Injection 1 ml with Ketoconazole may increase the risk of liver problems.
How to manage the interaction:
There may be a possible interaction between Dynapar AQ 75 mg Injection 1 ml and Ketoconazole, but they can be taken together if a doctor has prescribed them. However, consult a doctor immediately if you have fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark colored urine, light colored stools, and/or yellowing of the skin or eyes. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Co-administration of Dynapar AQ 75 mg Injection 1 ml and tenofovir alafenamide may cause kidney problems.
How to manage the interaction:
There may be a possible interaction between Dynapar AQ 75 mg Injection 1 ml and Tenofovir alafenamide but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience symptoms such as such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Do not stop using any medications without talking to your doctor.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Taking Dynapar AQ 75 mg Injection 1 ml with Omacetaxine mepesuccinate can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Dynapar AQ 75 mg Injection 1 ml and Omacetaxine mepesuccinate but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding or have other signs of bleeding like dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headaches. Do not discontinue any medications without consulting your doctor.
How does the drug interact with Dynapar AQ 75 mg Injection 1 ml:
Taking Dynapar AQ 75 mg Injection 1 ml with Ponatinib can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possible interaction between Dynapar AQ 75 mg Injection 1 ml and Ponatinib, but they can be taken together if your doctor has prescribed them. However, consult your doctor immediately if you experience any unusual bleeding, dizziness, lightheadedness, red or black, tarry stools, coughing up or vomiting fresh or dried blood that looks like coffee grounds, severe headaches. Do not discontinue any medications without consulting your doctor.